Targets and assays for Tuberculosis  drug development

  • Überblick

    Tuberculosis (TB) is one of the major human infectious diseases killing about two million people each year. High prevalence and mortality in combination with HIV in TB endemic countries poses a serious health problem which currently is getting out of control in developing countries in Africa and Asia. There is an urgent need for developing new drugs active against the currently emerging drug resistant strains.
    Results of our research on identification of drug targets and novel assays shall be presented.


    Datum: 27.01.2012, 11:00

    Veranstaltungsort

    Saarland University, Campus E1.3

    Referent

    Prof. Dr. Mahavir Singh, Helmholtz-Zentrum für Infektionsforschung, Braunschweig

    Gastgeber

    HIPS-DDOP, Rolf Hartmann